Author: Jade Passey

The National Institute for Health and Care Excellence (NICE) has approved the combination treatment of dabrafenib and trametinib to treat childhood gliomas.

CAR-T cell therapy is a type of immunotherapy that may be promising for treating brain tumours. There is lots of research in this field across the globe and it may one day be used more widely to treat this devastating disease.

Peter Buckle is a patient advocate and has worked with several teams, including the ARISTOCRAT team to champion research and clinical trials.

Living with a lower-grade glioma has a profound impact on those diagnosed, and their families. This is well documented anecdotally but needs to be scientifically addressed so that everyone affected by a brain tumour diagnosis gets the help and support they need.

A new nanosurgical tool – about 500 times thinner than a human hair – could help us understand how glioblastomas become resistant to radio- and chemotherapy. Up until now, no other technology has been able to do this.

Five years on, Nikki Saunders shares her experience of both her mum and brother being diagnosed with a glioblastoma.

Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas.

Natalie McKenna-Mounty was diagnosed with a glioblastoma in 2020, her tumour returned in June this year, and now she is supporting our new research funding to find better glioblastoma treatments.

The Ways Ahead project aims to find ways to support, and improve quality of life for those diagnosed with a lower-grade brain tumour. It also explores ways to help friends and family who are supporting those diagnosed.

Zachery Eckworth, now 11 years and living in Hampshire, was just 14 months old when we was diagnosed with an optic nerve glioma.

Researchers from the University of Sheffield ran the Sheffield 10K on 24th September to raise money for us, a charity close to their hearts.

He has raised more than £29,000 for The Charity in memory of his sister, Emily.

Layla Mistry, now nine, from Sonning, in Berkshire, was just two when she was diagnosed with medulloblastoma in July 2016.

Lizzie Bramall, from Nayland, was just nine when she was diagnosed with a diffuse midline glioma – one of the most aggressive paediatric high-grade gliomas.

Researchers involved in the Tessa Jowell BRAIN MATRIX study are calling for improvements to speed up the way brain tumours are diagnosed.

Toni O’Callaghan tells us about her son Jay’s glioblastoma diagnosis in 2021 and highlights the importance of funding glioblastoma research.

We are pleased to announce that we have awarded £4.5 million to three new, exciting research initiatives.

Laura Smallbone’s husband, Peter, died on 8th July 2022 after his glioblastoma recurred and there were no remaining treatment options available.

Experts at University College London, Queen Mary University of London and Great Ormond Street Hospital are to develop pioneering treatments for children diagnosed with low-grade brain tumours.

An international phase 3 clinical trial has shown that a new targeted therapy to treat low-grade gliomas can slow the progression of the disease. These findings have the potential to offer a new treatment option for those diagnosed with a grade 2 glioma.

Mia Bowater-Wragg, 26, from Sheffield, received a glioblastoma diagnosis in March 2021, having first learned that she had a brain tumour in 2018.

Whole genome sequencing is the scientific term used when scientists sequence DNA.

Researchers at the University of Birmingham are paving the way to improve brain tumour treatment in a revolutionary study which collects detailed information about a person’s tumour.

Researchers at the University of Toronto have identified a biomarker that can predict how aggressive meningiomas may be in those diagnosed with this type of brain tumour.